Literature DB >> 20516063

Transcriptional repression by sumoylation of Epstein-Barr virus BZLF1 protein correlates with association of histone deacetylase.

Takayuki Murata1, Naoe Hotta, Shigenori Toyama, Sanae Nakayama, Shigeki Chiba, Hiroki Isomura, Takayuki Ohshima, Teru Kanda, Tatsuya Tsurumi.   

Abstract

The transition from latent to lytic phases of the Epstein-Barr virus life cycle is triggered by expression of a viral transactivator, BZLF1, that then induces expression of the viral immediate-early and early genes. The BZLF1 protein is post-translationally modified by a small ubiquitin-related modifier-1 (SUMO-1). Here we found that BZLF1 is conjugated at lysine 12 not only by SUMO-1 but also by SUMO-2 and 3. The K12R mutant of BZLF1, which no longer becomes sumoylated, exhibits stronger transactivation than the wild-type BZLF1 in a reporter assay system as well as in the context of virus genome with nucleosomal structures. Furthermore, exogenous supply of a SUMO-specific protease, SENP, caused de-sumoylation of BZLF1 and enhanced BZLF1-mediated transactivation. Immunoprecipitation experiments proved that histone deacetylase 3 preferentially associated with the sumoylated form of BZLF1. Levels of the sumoylated BZLF1 increased as lytic replication progressed. Based on these observations, we conclude that sumoylation of BZLF1 regulates its transcriptional activity through histone modification during Epstein-Barr virus productive replication.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20516063      PMCID: PMC2911316          DOI: 10.1074/jbc.M109.095356

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  58 in total

1.  Sumoylation of the Epstein-Barr virus BZLF1 protein inhibits its transcriptional activity and is regulated by the virus-encoded protein kinase.

Authors:  Stacy R Hagemeier; Sarah J Dickerson; Qiao Meng; Xianming Yu; Janet E Mertz; Shannon C Kenney
Journal:  J Virol       Date:  2010-02-24       Impact factor: 5.103

2.  HTLV-1 HBZ suppresses AP-1 activity by impairing both the DNA-binding ability and the stability of c-Jun protein.

Authors:  Jun Matsumoto; Takayuki Ohshima; Osamu Isono; Kunitada Shimotohno
Journal:  Oncogene       Date:  2005-02-03       Impact factor: 9.867

3.  Histone acetylation and reactivation of Epstein-Barr virus from latency.

Authors:  P J Jenkins; U K Binné; P J Farrell
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

4.  Differential effect of TPA on cell growth and Epstein-Barr virus reactivation in epithelial cell lines derived from gastric tissues and B cell line Raji.

Authors:  M Kanamori; M Tajima; Y Satoh; Y Hoshikawa; Y Miyazawa; K Okinaga; T Kurata; T Sairenji
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

5.  Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies.

Authors:  A L Adamson; S Kenney
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

6.  Stimulation of CREB binding protein nucleosomal histone acetyltransferase activity by a class of transcriptional activators.

Authors:  C J Chen; Z Deng; A Y Kim; G A Blobel; P M Lieberman
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

7.  Roles of Epstein-Barr virus glycoproteins gp350 and gp25 in the infection of human epithelial cells.

Authors:  Seiji Maruo; Lixin Yang; Kenzo Takada
Journal:  J Gen Virol       Date:  2001-10       Impact factor: 3.891

8.  The Epstein-Barr virus BZLF1 protein interacts physically and functionally with the histone acetylase CREB-binding protein.

Authors:  A L Adamson; S Kenney
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

9.  Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3.

Authors:  H Saitoh; J Hinchey
Journal:  J Biol Chem       Date:  2000-03-03       Impact factor: 5.157

Review 10.  Latent and lytic Epstein-Barr virus replication strategies.

Authors:  Tatsuya Tsurumi; Masatoshi Fujita; Ayumi Kudoh
Journal:  Rev Med Virol       Date:  2005 Jan-Feb       Impact factor: 6.989

View more
  20 in total

Review 1.  Human pathogens and the host cell SUMOylation system.

Authors:  Peter Wimmer; Sabrina Schreiner; Thomas Dobner
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  Identification and characterization of CCAAT enhancer-binding protein (C/EBP) as a transcriptional activator for Epstein-Barr virus oncogene latent membrane protein 1.

Authors:  Chieko Noda; Takayuki Murata; Teru Kanda; Hironori Yoshiyama; Atsuko Sugimoto; Daisuke Kawashima; Shinichi Saito; Hiroki Isomura; Tatsuya Tsurumi
Journal:  J Biol Chem       Date:  2011-10-19       Impact factor: 5.157

3.  Repression of CIITA by the Epstein-Barr virus transcription factor Zta is independent of its dimerization and DNA binding.

Authors:  Nicolae Balan; Kay Osborn; Alison J Sinclair
Journal:  J Gen Virol       Date:  2015-12-11       Impact factor: 3.891

Review 4.  Viral manipulation of cellular protein conjugation pathways: The SUMO lesson.

Authors:  Domenico Mattoscio; Chiara V Segré; Susanna Chiocca
Journal:  World J Virol       Date:  2013-05-12

5.  Contribution of myocyte enhancer factor 2 family transcription factors to BZLF1 expression in Epstein-Barr virus reactivation from latency.

Authors:  Takayuki Murata; Yohei Narita; Atsuko Sugimoto; Daisuke Kawashima; Teru Kanda; Tatsuya Tsurumi
Journal:  J Virol       Date:  2013-07-10       Impact factor: 5.103

6.  SUMO binding by the Epstein-Barr virus protein kinase BGLF4 is crucial for BGLF4 function.

Authors:  Renfeng Li; Leyao Wang; Gangling Liao; Catherine M Guzzo; Michael J Matunis; Heng Zhu; S Diane Hayward
Journal:  J Virol       Date:  2012-03-07       Impact factor: 5.103

7.  Biochemical analysis of protein SUMOylation.

Authors:  Aileen Y Alontaga; Ekaterina Bobkova; Yuan Chen
Journal:  Curr Protoc Mol Biol       Date:  2012-07

8.  Epigenetic histone modification of Epstein-Barr virus BZLF1 promoter during latency and reactivation in Raji cells.

Authors:  Takayuki Murata; Yutaka Kondo; Atsuko Sugimoto; Daisuke Kawashima; Shinichi Saito; Hiroki Isomura; Teru Kanda; Tatsuya Tsurumi
Journal:  J Virol       Date:  2012-02-22       Impact factor: 5.103

9.  Involvement of Jun dimerization protein 2 (JDP2) in the maintenance of Epstein-Barr virus latency.

Authors:  Takayuki Murata; Chieko Noda; Shinichi Saito; Daisuke Kawashima; Atsuko Sugimoto; Hiroki Isomura; Teru Kanda; Kazunari K Yokoyama; Tatsuya Tsurumi
Journal:  J Biol Chem       Date:  2011-04-27       Impact factor: 5.157

Review 10.  Function and regulation of SUMO proteases.

Authors:  Christopher M Hickey; Nicole R Wilson; Mark Hochstrasser
Journal:  Nat Rev Mol Cell Biol       Date:  2012-12       Impact factor: 94.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.